Physician profile
Anthony D Alfieri
NPI 1184604274
$45,382.24
in general payments reported to CMS, 2019-2025
54 companies · $1,884 in 2025
The $1,884 reported for 2025 was more than what 83% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,774 · 2020: $1,988 · 2021: $21K · 2022: $13K · 2023: $2,592 · 2024: $2,690 · 2025: $1,884.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,134 · Education: $32.23.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,133.56 |
| Education | $32.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $29,437.63 | 2020-2025 | Nexletol |
| Janssen Pharmaceuticals, INC | $1,699.55 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $1,614.25 | 2019-2025 | Brilinta, Farxiga, Wainua |
| Novo Nordisk INC | $1,610.07 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Novartis Pharmaceuticals Corporation | $1,504.71 | 2019-2025 | |
| Amgen INC. | $1,048.79 | 2019-2025 | Repatha, Repatha |
| Lilly USA, LLC | $967.17 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Bayer Healthcare Pharmaceuticals INC. | $853.33 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $824.00 | 2021-2025 | Verquvo, Capvaxive |
| Axsome Therapeutics, INC. | $655.81 | 2022-2025 | Sunosi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $638.11 | 2019-2025 | Jardiance |
| Pfizer INC. | $501.77 | 2019-2025 | |
| Jazz Pharmaceuticals INC. | $470.42 | 2019-2022 | |
| Amarin Pharma, INC. | $419.26 | 2019-2022 | |
| Boston Scientific Corporation | $349.56 | 2019-2025 | Varithena Administration Pack, Cds - Mct/Cem Monitoring, Bodyguardian |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $331.62 | 2024-2025 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| E.R. Squibb & Sons, L.L.C. | $275.17 | 2019-2025 | Camzyos, Eliquis |
| Bard Peripheral Vascular, INC. | $208.57 | 2022-2023 | Venclose Maven Catheter |
| Medtronic, INC. | $201.77 | 2021-2025 | Closurefast, Venaseal |
| Heartflow, INC. | $179.35 | 2022-2024 | |
| Sanofi-Aventis U.S. LLC | $178.09 | 2020-2023 | |
| Lexicon Pharmaceuticals, INC. | $171.55 | 2023-2024 | Inpefa |
| Regeneron Healthcare Solutions, INC. | $141.18 | 2019-2021 | |
| Alnylam Pharmaceuticals INC. | $127.47 | 2019-2024 | |
| Scpharmaceuticals INC. | $105.36 | 2024-2025 | |
| Bridgebio Pharma, INC. | $74.09 | 2025 | Attruby |
| Abbott Laboratories | $68.98 | 2024-2025 | Freestyle Libre 3 |
| Currax Pharmaceuticals LLC | $61.13 | 2022-2023 | Contrave, Onzetra Xsail |
| Tactile Systems Technology INC | $55.45 | 2025 | Nimbl, Flexitouch Plus |
| Amryt Pharma Holdings LTD | $49.51 | 2021-2023 | Juxtapid |
| Angiodynamics, INC. | $49.38 | 2025 | Venacure 1470 Pro |
| Genentech USA, INC. | $39.96 | 2021-2022 | |
| Irhythm Technologies, INC. | $39.43 | 2024 | Zio Monitor, Zio Xt Patch |
| Chiesi USA, INC. | $38.33 | 2024-2025 | Juxtapid |
| United Therapeutics Corporation | $35.07 | 2019-2021 | |
| Lundbeck LLC | $30.19 | 2019 | |
| Medicomp INC | $29.12 | 2024 | Telepatch Cardiac Monitor |
| Cashflow Solutions, LLC | $29.11 | 2023-2024 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Kowa Pharmaceuticals America, INC. | $25.69 | 2019 | |
| Xeris Pharmaceuticals, INC. | $23.47 | 2024 | Gvoke Hypopen |
| Biotronik INC. | $22.52 | 2025 | Biomonitor |
| Exact Sciences Corporation | $22.15 | 2025 | The Cologuard Plus Collection Kit |
| Abbvie INC. | $20.24 | 2022 | |
| Acarix USA INC. | $20.23 | 2023 | Cadscor System |
| Biocompatibles, INC. | $19.08 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $17.70 | 2023 | Arcalyst |
| Philips North America LLC | $17.33 | 2020 | |
| Vivaquant INC, Dba Rhythm Express | $16.95 | 2024 | Rhythm Express |
| Nalpropion Pharmaceuticals LLC | $16.77 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $16.35 | 2024 | Arcalyst |
| Bardy Diagnostics, INC. | $15.00 | 2021 | |
| Agepha Pharma Fz LLC | $14.45 | 2025 | Lodoco |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Alfieri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.